tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Neena Bitritto-Garg, 27 are a HOLD (50%), 26 are a BUY (48.15%), 1 are a SELL (1.85%).
Analyst Neena Bitritto-Garg, currently employed at DEUTSCHE BANK, carries an average stock price target met ratio of 86.39% that have a potential upside of 63.26% achieved within 269 days.
Neena Bitritto-Garg’s has documented 108 price targets and ratings displayed on 6 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ACAD, ACADIA Pharmaceuticals at 12-Dec-2023.
Analyst best performing recommendations are on SAGE (SAGE THERAPEUTIC).
The best stock recommendation documented was for ACAD (ACADIA PHARMACEUTICALS) at 12/12/2023. The price target of $25 was fulfilled within 1 day with a profit of $3.83 (18.09%) receiving and performance score of 180.92.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$27
$9.87 (57.62%)
$27
1 months ago
(07-Nov-2024)
8/22 (36.36%)
$9.79 (56.89%)
119
Buy
$28
$10.87 (63.46%)
$28
1 months ago
(07-Nov-2024)
0/4 (0%)
$10.79 (62.70%)
Hold
1 months 27 days ago
(10-Oct-2024)
11/14 (78.57%)
$9.98 (39.89%)
141
Buy
$23
$5.87 (34.27%)
$30
3 months 29 days ago
(08-Aug-2024)
0/3 (0%)
$7.28 (46.31%)
Buy
$20
$2.87 (16.75%)
$28
4 months ago
(07-Aug-2024)
16/21 (76.19%)
$4.83 (31.84%)
184
What Year was the first public recommendation made by Neena Bitritto-Garg?
